Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(4.53)
# 267
Out of 5,152 analysts
76
Total ratings
50.67%
Success rate
38.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Assumes: Buy | $22 | $5.70 | +285.96% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $2.19 | +357.67% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $8.02 | +398.75% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.13 | +784.96% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $15.54 | -61.39% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $5.63 | +131.11% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $22.50 | -11.11% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.82 | +295.19% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $60.37 | +24.23% | 13 | Apr 28, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $36 | $12.78 | +181.69% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.62 | +2,314.29% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $8.71 | +187.03% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $46.15 | +8.34% | 13 | Nov 26, 2024 |
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $5.70
Upside: +285.96%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $2.19
Upside: +357.67%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $8.02
Upside: +398.75%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.13
Upside: +784.96%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $15.54
Upside: -61.39%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $5.63
Upside: +131.11%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $22.50
Upside: -11.11%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $5.82
Upside: +295.19%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $60.37
Upside: +24.23%
Day One Biopharmaceuticals
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $12.78
Upside: +181.69%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.62
Upside: +2,314.29%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $8.71
Upside: +187.03%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $46.15
Upside: +8.34%